Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Upgrades

Upgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

JP Morgan Upgrades Meritage Homes to Overweight, Announces $129 Price Target

By Benzinga Newsdesk
March 6, 6:45 AM
JP Morgan analyst Michael Rehaut upgrades Meritage Homes (NYSE:MTH) from Neutral to Overweight and announces $129 price target.

MTH

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Baird Upgrades REV Group to Outperform, Announces $16 Price Target

By Benzinga Newsdesk
March 6, 6:02 AM
Baird analyst Mircea Dobre upgrades REV Group (NYSE:REVG) from Neutral to Outperform and announces $16 price target.

REVG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas
  • Upgrades

Analyst Upgrades This Radiology Stock, Expects Promising 2023 Ahead

By Vandana Singh
March 3, 2:38 PM
Raymond James upgraded Radnet Inc (NASDAQ:RDNT) from Market Perform to Outperform and a price target of $30 following 4Q22 results that came in…

RDNT

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Earnings
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Upgrades

Analyst Upgrades This Stock And Doubles Price Target On Encouraging Ibsrela Story

By Vandana Singh
March 3, 2:34 PM
After the market close Thursday, Ardelyx Inc (NASDAQ:ARDX) reported Q4 FY22 Ibsrela sales of $8.7 million and $15.6 million for FY22. The…

ARDX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Upgrades

Bilibili Likely To Gain From New Game Launches, Auto, 3C And Recovery In Performance Based Ads, Analysts Say

By Anusuya Lahiri
March 3, 1:43 PM
Citigroup analyst Brian Gong upgrades Bilibili Inc (NASDAQ: BILI) from 

BILI

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Trading Ideas
  • Upgrades

Why This Procter & Gamble Analyst Is Turning Bullish After Shares Down For Past Year

By Priya Nigam
March 3, 12:50 PM
Shares of Procter & Gamble Co (NYSE: PG) have lost more than 7% year to date. The company is poised to return to compounding earnings ahead, according to JPMorgan.

PG

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Craig-Hallum Upgrades LivePerson to Buy, Raises Price Target to $15

By Benzinga Newsdesk
March 3, 10:01 AM
Craig-Hallum analyst Jeff Van Rhee upgrades LivePerson (NASDAQ:LPSN) from Hold to Buy and raises the price target from $13 to $15.

LPSN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Evercore ISI Group Upgrades Neurocrine Biosciences to Outperform, Announces $130 Price Target

By Benzinga Newsdesk
March 3, 9:58 AM
Evercore ISI Group analyst Joshua Schimmer upgrades Neurocrine Biosciences (NASDAQ:NBIX) from In-Line to Outperform and announces $130 price target.

NBIX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

UBS Upgrades First Solar to Buy, Raises Price Target to $250

By Benzinga Newsdesk
March 3, 9:14 AM
UBS analyst Jon Windham upgrades First Solar (NASDAQ:FSLR) from Neutral to Buy and raises the price target from $140 to $250.

FSLR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

Scotiabank Upgrades Toronto-Dominion Bank to Sector Outperform

By Benzinga Newsdesk
March 3, 7:54 AM
Scotiabank analyst Meny Grauman upgrades Toronto-Dominion Bank (TSX:TD) from Sector Perform to Sector Outperform.

TD

Posts pagination

Previous 1 … 83 84 85 … 188 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service